the Fetal Epicardial Thickness in Obese Pregnant Women (EFT)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the effects of fetal EFT on fetal cardiac function and fetal and maternal outcomes were investigated in obese pregnant women compared with normal-weight pregnant women.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antecedents of Obesity: Fetal Measures of Adiposity

NCT00715754

Obesity

COMPLETED

Magnetic Resonance Imaging and Thermal Imaging of Adiposity in Neonates of Women With Metabolic Diseases

NCT04890886

Diabetes Mellitus Intrahepatic Cholestasis of Pregnancy Metabolic Disease

UNKNOWN

PED NEONAT 20-000599 Fetal Body Composition

NCT04508751

IUGR Gestational Diabetes Pregnancy Related

COMPLETED PHASE1

White Adipose Tissue in Pregnancy Study

NCT02495987

ICP GDM

ACTIVE_NOT_RECRUITING

Association of Obesity and Cardiovascular Outcomes in Hypertrophic Cardiomyopathy

NCT05645939

Obesity Hypertrophic Cardiomyopathy Cardiovascular Morbidity

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All pregnant women underwent a comprehensive fetal anomaly screening. One obstetrician (S.D.) assessed all of the measurements. Every measurement was performed using a convex 2-5 MHz Voluson E8 probe (GE Healthcare, Milwaukee, WI). Fetal biometry, UA, MCA Doppler, cerebroplacental ratio (CPR), modified MPI (mod-MPI), and EFT were assessed in accordance with the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) guidelines

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fetus Fetus Pregnancy Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

case control

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

obese and non obese pregnant women

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

myocardial performance and epicard thickness in obese pregnant women

obese pregnant versus normal-weight pregnant women were evaluated for MPI and fetal epicardial thickness

Group Type ACTIVE_COMPARATOR

Doppler ultrasonography

Intervention Type DIAGNOSTIC_TEST

Doppler study was performed in all cases. perinatal outcomes were evaluated.

obese pregnant

obese pregnant versus normal-weight pregnant women were evaluated for MPI and fetal epicardial thickness

Group Type ACTIVE_COMPARATOR

Doppler ultrasonography

Intervention Type DIAGNOSTIC_TEST

Doppler study was performed in all cases. perinatal outcomes were evaluated.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Doppler ultrasonography

Doppler study was performed in all cases. perinatal outcomes were evaluated.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Obese pregnant women
* normal-weight pregnant women
* 24-40 gestational week

Exclusion Criteria

Twin pregnancies, structural and chromosomal abnormalities, fetal rhesus isoimmunization, fetal growth restriction, cases with infections detected by maternal serological tests, pregestational or gestational diabetes (All patients underwent a 75-gram glucose load test at 24 weeks to rule out diabetes), preeclampsia, premature rupture of membranes were excluded from the study -

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes